These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2201205)

  • 1. Efficacy of nifedipine to prevent systemic and renal vasoconstrictor effects of endothelin.
    Madeddu P; Yang XP; Anania V; Troffa C; Pazzola A; Soro A; Manunta P; Tonolo G; Demontis MP; Varoni MV
    Am J Physiol; 1990 Aug; 259(2 Pt 2):F304-11. PubMed ID: 2201205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protective effect of a calcium antagonist against renal vasoconstriction induced by endothelin in the normotensive rat].
    Madeddu P; Pala F; Troffa C; Pinna Parpaglia P; Pazzola A; Soro A; Manunta P; Tonolo G; Melis MG; Demontis MP
    Boll Soc Ital Biol Sper; 1990 Jul; 66(7):671-8. PubMed ID: 2083061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of endothelin and Ca++ entry blockers on renal circulation in anesthetized rabbits.
    Seino M; Abe K; Nushiro N; Omata K; Tsunoda K; Yoshinaga K; Kasai Y; Saito T; Sasao S
    Clin Exp Hypertens A; 1990; 12(2):205-13. PubMed ID: 2189604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct visualization of effects of endothelin on the renal microvasculature.
    Loutzenhiser R; Epstein M; Hayashi K; Horton C
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F61-8. PubMed ID: 2405711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the cardiovascular actions of endothelin in vivo: comparisons with neuropeptide Y and angiotensin II.
    Pernow J
    Acta Physiol Scand; 1989 Nov; 137(3):421-6. PubMed ID: 2596335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin: a potent renal and systemic vasoconstrictor peptide.
    King AJ; Brenner BM; Anderson S
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F1051-8. PubMed ID: 2660593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin-1-induced renal vasoconstriction is blunted by enalaprilat and enhanced by EDRF antagonist in awake normotensive rats.
    Madeddu P; Anania V; Parpaglia PP; Troffa C; Pazzola A; Soro A; Manunta P; Tonolo G; Demontis MP; Varoni MV
    Clin Invest Med; 1991 Dec; 14(6):600-6. PubMed ID: 1665404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential inhibitory effect of nifedipine on angiotensin II-induced renal vasoconstriction.
    Imagawa J; Kusaba-Suzuki M; Satoh S
    Hypertension; 1986 Oct; 8(10):897-903. PubMed ID: 3531005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic and pharmacological evaluation of the vasodilator and vasoconstrictor effects of endothelin-1 in rats.
    Le Monnier de Gouville AC; Mondot S; Lippton H; Hyman A; Cavero I
    J Pharmacol Exp Ther; 1990 Jan; 252(1):300-11. PubMed ID: 2405151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional hemodynamic effects of endothelin-2 and sarafotoxin-S6b in conscious rats.
    Gardiner SM; Compton AM; Bennett T
    Am J Physiol; 1990 Apr; 258(4 Pt 2):R912-7. PubMed ID: 2184684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of regional responses to endothelin in hindquarters vascular bed of cats.
    Minkes RK; MacMillan LA; Bellan JA; Kerstein MD; McNamara DB; Kadowitz PJ
    Am J Physiol; 1989 Feb; 256(2 Pt 2):H598-602. PubMed ID: 2464946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic hemodynamic effects of endothelin in rats.
    King AJ; Pfeffer JM; Pfeffer MA; Brenner BM
    Am J Physiol; 1990 Mar; 258(3 Pt 2):H787-92. PubMed ID: 2180322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal vascular responses in spontaneously hypertensive rats chronically treated with manidipine.
    Muratani H; Takishita S; Kawazoe N; Tozawa M; Fukiyama K
    Blood Press Suppl; 1992; 3():60-7. PubMed ID: 1343293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium intake modulates renal vascular reactivity to endothelin-1 in Dahl rats.
    Grossman E; Hoffman A; Keiser HR
    Clin Exp Pharmacol Physiol; 1990 Feb; 17(2):121-8. PubMed ID: 2183958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice lacking the ADP ribosyl cyclase CD38 exhibit attenuated renal vasoconstriction to angiotensin II, endothelin-1, and norepinephrine.
    Thai TL; Arendshorst WJ
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F169-76. PubMed ID: 19403649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine augments renal but not systemic vascular reactivity.
    Garr MD; Paller MS
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F211-7. PubMed ID: 2301592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations in cell signaling pathways for different vasoconstrictor agonists in renal circulation of the rat.
    Bauer J; Parekh N
    Kidney Int; 2003 Jun; 63(6):2178-86. PubMed ID: 12753305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II.
    Cediel E; de Las Heras N; Sanz-Rosa D; Velasco O; Cachofeiro V; Lahera V
    Kidney Int Suppl; 2005 Jan; (93):S3-9. PubMed ID: 15613065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term ANG II produces renal vasoconstriction independent of TP receptor activation and TxA2/isoprostane production.
    Vågnes ØB; Iversen BM; Arendshorst WJ
    Am J Physiol Renal Physiol; 2007 Sep; 293(3):F860-7. PubMed ID: 17567934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of endothelin on renal function in dogs and rats.
    Banks RO
    Am J Physiol; 1990 Apr; 258(4 Pt 2):F775-80. PubMed ID: 2184673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.